Burmeister, Thomas http://orcid.org/0000-0003-4843-2876
Ströh, Aeint-Steffen http://orcid.org/0000-0002-7463-5354
Kehden, Britta
Trautmann, Heiko http://orcid.org/0000-0002-9000-4747
Meyer, Claus
Marschalek, Rolf http://orcid.org/0000-0003-4870-3445
Larghero, Patrizia
Schwartz, Stefan http://orcid.org/0000-0001-8833-5793
Steffen, Björn http://orcid.org/0009-0002-6693-4079
Spriewald, Bernd
Heinicke, Thomas http://orcid.org/0000-0002-4049-7854
Jäkel, Nadja http://orcid.org/0000-0001-6162-515X
Westermann, Jörg
Nachtkamp, Kathrin
Viardot, Andreas
Topp, Max S.
Neumann, Martin
Baldus, Claudia D. http://orcid.org/0000-0002-0748-834X
Gökbuget, Nicola
Brüggemann, Monika
Article History
Received: 30 July 2023
Revised: 28 February 2024
Accepted: 28 February 2024
First Online: 22 March 2024
Competing interests
: MB is contracted to carry out research for Affimed, Amgen, Regeneron, the advisory board of Amgen, Incyte, Speaker bureau of Amgen, Janssen, Pfizer, Roche. SS is advisory board member of AMGEN and received honoraria as a speaker bureau member of AMGEN. CB is contracted to carry out research for Novartis, the advisory board of Amgen. TB received speakers’ honoraria from Novartis and Pfizer. The other authors declare that they have no conflict of interest.